Concepedia

Long-Term Outcome of Patients With Crohn’s Disease Who Discontinued Infliximab Therapy Upon Clinical Remission

Konstantinos Papamichael, Niels Vande Casteele, Ann Gils, Sophie Tops, Scott Hauenstein, Sharat Singh, Fred Princen, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire,

Clinical Gastroenterology and Hepatology · 2014 · 81 citations · 17 references

DOI

Concepts

References

17

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

Filip Baert, Maja Noman, Séverine Vermeire et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

, , +17

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

Fabian Schnitzler, Herma H. Fidder, Marc Ferrante et al. · Inflammatory Bowel Diseases · 2009 · 672 citations · Full text

, , +14

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Édouard Louis, Jean‐Yves Mary, Gwénola Vernier-Massouille et al. · Gastroenterology · 2011 · 593 citations · Full text

, , +14

Selected loss of tolerance evidenced by Crohn's disease–associated immune responses to auto- and microbial antigens

Carol J. Landers, Offer Cohavy, Rajeev Misra et al. · Gastroenterology · 2002 · 438 citations · Full text

, , +16

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

Marc Ferrante, Liesbet Henckaerts, Marie Joossens et al. · Gut · 2007 · 292 citations · Full text

, , +17